FIELD: chemistry.
SUBSTANCE: invention refers to a glycolipid compound applicable in medicine, selected from a compound of formula (I), (II) and (III) or its pharmaceutically acceptable salt:
(I)
(II)
(III).
EFFECT: novel effective compounds for inducing a protective anti-tumour immune response and a pharmaceutical composition based thereon for treating tumours.
11 cl, 5 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL ANTIBODY CONJUGATES AND USES THEREOF | 2014 |
|
RU2684468C2 |
| THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
| ANTI-HER2 ANTIBODY-DRUG CONJUGATE | 2015 |
|
RU2683780C2 |
| ANTI-HER2 ANTIBODY DRUG CONJUGATE | 2015 |
|
RU2794183C2 |
| CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | 2013 |
|
RU2649009C2 |
| DERIVATIVES OF PIPERIDINE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2279425C2 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
| ANTI-TROP2 ANTIBODY-DRUG CONJUGATE | 2014 |
|
RU2705367C2 |
| ANTI-HER3 ANTIBODY-DRUG CONJUGATE | 2015 |
|
RU2711640C2 |
| ANTIBODY-DRUG CONJUGATE | 2013 |
|
RU2664465C2 |
